Artificial saliva refers to a synthetic product designed to mimic the properties and functions of natural saliva. It is used to relieve dryness in the mouth (xerostomia) caused by various conditions such as Sjögren’s syndrome, radiation therapy for cancer, or certain medications. Artificial saliva helps to moisten and lubricate the mouth, aids in chewing and swallowing, and can improve overall oral comfort.
Sizing and Forecast
The artificial saliva market size has grown rapidly in recent years. It will grow from $1.72 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to growing demand for oral sprays, oral gels, and oral liquids, expanding treatment options for cancer patients, growing aging population, rising disposable income, rise in dental disorders among individuals worldwide.
The artificial saliva market size is expected to see rapid growth in the next few years. It will grow to $3.27 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to growing awareness about the importance of oral hygiene, escalating prevalence of dry mouth syndrome (xerostomia), increasing demand for artificial saliva, rising incidents of cancer, prevalence of cancer and surge in chemotherapy treatment. Major trends in the forecast period include increasing R and D activities, advancements in product formulation, integration with advanced technologies, technological developments in dry mouth treatment, shift towards natural and biocompatible ingredients.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/artificial-saliva-global-market-report
Segmentation & Regional Insights
The artificial saliva market covered in this report is segmented –
1) By Product: Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder
2) By Distributional Channel: Supermarkets, Hypermarkets, Other Distribution Channels
3) By End-User: Adult, Pediatric
North America was the largest region in the artificial saliva market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial saliva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16592&type=smp
Major Driver Impacting Market Growth
The rising prevalence of dry mouth syndrome is expected to propel the growth of the artificial saliva market going forward. Dry mouth syndrome, also known as xerostomia, refers to the condition characterized by a persistent feeling of dryness in the mouth. The prevalence of dry mouth syndrome has increased partly due to an aging population and the widespread use of medications and over-the-counter drugs that can cause the xerostomia effect. Artificial saliva provides moisture to the oral tissues, helping to relieve the dry, sticky feeling commonly associated with xerostomia. For instance, according to a study by Faculdade Meridional, a Brazil-based dentistry school, a sample of 293 older adults in Brazil had a xerostomia prevalence rate of 19.1% in 2021. Similarly, according to another research study by the University of Gothenburg, a Sweden-based University, in a cross-sectional survey of 374 adult patients seeking primary healthcare in 2022, xerostomia had a prevalence rate of 43.6%. Therefore, the rising prevalence of dry mouth syndrome is driving the growth of the artificial saliva market.
Key Industry Players
Major companies operating in the artificial saliva market are Pfizer Inc., Amgen Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Cipla, Hikma Pharmaceuticals plc, RECORDATI, Mankind Pharma Ltd., Quantum Health Inc., Mission Pharmacal Company, Cumberland Pharmaceuticals Inc., DENTAID, Parnell Pharmaceuticals Inc., Forward Science, ICPA Health Products Ltd., Saliwell Ltd., Livealth, CCMed Ltd., Nanochemazone
The artificial saliva market report table of contents includes:
1. Executive Summary
- Artificial Saliva Market Characteristics
- Artificial Saliva Market Trends And Strategies
- Artificial Saliva Market – Macro Economic Scenario
- Global Artificial Saliva Market Size and Growth
. 32. Global Artificial Saliva Market Competitive Benchmarking - Global Artificial Saliva Market Competitive Dashboard
- Key Mergers And Acquisitions In The Artificial Saliva Market
- Artificial Saliva Market Future Outlook and Potential Analysis
36. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
